APA

Castagnoli L., Ghedini G. C., Koschorke A., Triulzi T., Dugo M., Gasparini P., Casalini P., Palladini A., Iezzi M., Lamolinara A., Lollini P. L., Nanni P., Chiodoni C., Tagliabue E. & Pupa S. M. (20170901). Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer. : Oncogene.

Chicago

Castagnoli L, Ghedini G C, Koschorke A, Triulzi T, Dugo M, Gasparini P, Casalini P, Palladini A, Iezzi M, Lamolinara A, Lollini P L, Nanni P, Chiodoni C, Tagliabue E and Pupa S M. 20170901. Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer. : Oncogene.

Harvard

Castagnoli L., Ghedini G. C., Koschorke A., Triulzi T., Dugo M., Gasparini P., Casalini P., Palladini A., Iezzi M., Lamolinara A., Lollini P. L., Nanni P., Chiodoni C., Tagliabue E. and Pupa S. M. (20170901). Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer. : Oncogene.

MLA

Castagnoli L, Ghedini G C, Koschorke A, Triulzi T, Dugo M, Gasparini P, Casalini P, Palladini A, Iezzi M, Lamolinara A, Lollini P L, Nanni P, Chiodoni C, Tagliabue E and Pupa S M. Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer. : Oncogene. 20170901.